In diabetes mellitus with increased HbAIC, drug that is not used in treatment is?
**Core Concept**
The management of diabetes mellitus involves various pharmacological agents to control blood glucose levels. HbA1c is a crucial marker for assessing glycemic control in diabetic patients. The choice of antidiabetic medication depends on the type of diabetes, severity of hyperglycemia, and presence of comorbidities.
**Why the Correct Answer is Right**
In patients with increased HbA1c, the primary goal is to improve glycemic control. Insulin is a crucial component in the management of diabetes, especially in type 1 diabetes and advanced type 2 diabetes. However, in some cases, especially in type 2 diabetes, oral antidiabetic medications are preferred to manage blood glucose levels.
**Why Each Wrong Option is Incorrect**
* **Option A:** Metformin is a first-line oral antidiabetic medication used in the treatment of type 2 diabetes. It works by decreasing glucose production in the liver and increasing insulin sensitivity. Therefore, metformin is used in the treatment of diabetes with increased HbA1c.
* **Option B:** Sulfonylureas stimulate insulin release from the pancreatic beta cells, thereby reducing blood glucose levels. They are used in the treatment of type 2 diabetes, especially in patients with inadequate glycemic control.
* **Option C:** Thiazolidinediones (TZDs) improve insulin sensitivity, reducing glucose levels in the blood. They are used in the treatment of type 2 diabetes, especially in patients with insulin resistance.
**Clinical Pearl / High-Yield Fact**
One should note that the choice of antidiabetic medication depends on the patient's renal function, as some medications like TZDs are contraindicated in patients with severe kidney disease.
**Correct Answer:** D